C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
VRNO US MSO

Verano Holdings

OTCMKTS · VRNO

Top-tier MSO with strong presence in Illinois and New Jersey. Redomiciled from BC to Nevada in Nov 2025.

$5.14
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 1/5
52/100 composite
Fundamentals71
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Verano Holdings earns a Neutral rating with a 51.6 composite score and low conviction of 1/5. Fundamentals provide the principal support at 71.0, driven by gross-margin and operating-margin subscores of 83.9 and 81.8, respectively, alongside a 90.0 cash-runway subscore reflecting positive EBITDA despite a net loss. Regulatory contributes a middling 49.0, supported by an 80.0 enforcement subscore but restrained by a 25.0 cadence subscore. Market scores 40.0 because no quote is available, while editorial ranks weakest at 30.0 amid no newsroom or brief activity. The resulting pillar mix places the shares squarely in the Neutral band rather than establishing a stronger directional case.

Licensed fundamentals data show year-over-year revenue contracting by approximately 0.8%, limiting the benefit from a gross margin just above 50.3% and an operating margin near 6.3%. EBITDA stands near $195.8 million, but the roughly $264.2 million net loss keeps the financial condition stretched and prevents operating profitability from translating into bottom-line strength. Market capitalization is approximately $419.1 million. Primary regulatory filings show the latest filing dated June 23, 2026, with no events during the latest 90-day period and two across 180 days. No enforcement hits support the regulatory pillar, although sparse filing cadence caps its contribution. Institutional pricing feeds provide no current quote, and CIN newsroom coverage records no qualifying news or brief hits, explaining the subdued market and editorial pillars.

The forward catalyst rests on fundamentals, particularly the durability of the company’s margin profile. Gross and operating profitability already represent the strongest measurable drivers, creating scope for a higher composite if revenue contraction reverses and EBITDA begins translating into materially improved net income. Greater filing frequency could reinforce visibility, but regulatory, market, and editorial scores presently lack enough strength to lead a rerating. The stretched condition keeps attention fixed on earnings conversion rather than EBITDA alone. The single most important signal to watch is whether the next primary regulatory filing shows renewed year-over-year revenue growth while preserving the current gross-margin profile.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
224 W HILL STREET, SUITE 400, CHICAGO, IL, 60610
Phone
312-265-0730
CEO
George Archos
CFO
Richard Tarapchak
Auditor
required
SEC CIK
1848416
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$419.1M
Enterprise value
$849.3M
Price to book
0.63
Price to sales
0.51
EV / EBITDA
36.79
Revenue (TTM)
$819.9M
Gross profit (TTM)
$412.9M
EBITDA
$195.8M
Operating margin
6.3%
Profit margin
-32.2%
Rev growth YoY
-0.8%
Return on equity
-32.5%
Return on assets
2.5%
EPS (TTM)
$-3.65
EPS est. current year
$-0.95
Wall St. target price
$25.00
Shares outstanding
73.9M
Insider ownership
14.3%
Institutional ownership
0.3%
Beta
1.40
Full-time employees
3,800
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Verano Holdings (VRNO)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Verano Holdings (VRNO), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss. (1 bullish signal, 3 bearish signals.)

Top-tier MSO with strong presence in Illinois and New Jersey. Redomiciled from BC to Nevada in Nov 2025.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for VRNO are maintained by Cannabis Investor News and refreshed throughout the trading day.